Luba Greenwood, JD, is the chief executive officer of Gallop Oncology. With over 20 years of leadership in healthcare and technology, including extensive global board experience, Ms. Greenwood has proven expertise in building transformative biotech companies.

Ms. Greenwood currently serves as the founder and managing partner of the Dana Farber Cancer Institute Venture Fund, Binney Street Capital (BSC), which builds and invests in companies across therapeutics, diagnostics, and digital sectors. She is also an entrepreneur-in-residence at PureTech Health where she plays a key role in PureTech’s oncology program and works with the senior leadership team and board on PureTech’s corporate strategy.

Prior to joining Gallop, Ms. Greenwood was the chief executive officer and chair of the Board of Kojin Therapeutics, a leader in ferroptosis. She is also a board member and board chair of multiple public, private and non-profit organizations, including Abcam, BenchSci, In8Bio, Closed Loop Medicines, IN8bio, Traws Pharma, Inc and MassBio. She also serves on the Investor Committee for the National Cancer Institute.